X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11383) 11383
Newsletter (276) 276
Book Chapter (58) 58
Newspaper Article (39) 39
Dissertation (33) 33
Publication (11) 11
Conference Proceeding (9) 9
Magazine Article (7) 7
Reference (3) 3
Web Resource (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
temozolomide (9625) 9625
humans (6582) 6582
oncology (5353) 5353
glioblastoma (4859) 4859
female (3254) 3254
chemotherapy (3230) 3230
radiotherapy (3203) 3203
male (3197) 3197
cancer (3183) 3183
middle aged (2594) 2594
dacarbazine - analogs & derivatives (2582) 2582
glioblastoma multiforme (2444) 2444
clinical neurology (2349) 2349
adult (2336) 2336
survival (2245) 2245
aged (2217) 2217
glioma (2121) 2121
tumors (2054) 2054
adjuvant temozolomide (2030) 2030
gliomas (2011) 2011
brain neoplasms - drug therapy (2002) 2002
brain neoplasms - pathology (1726) 1726
cell line, tumor (1544) 1544
animals (1521) 1521
prognosis (1511) 1511
glioblastoma - drug therapy (1469) 1469
brain tumors (1438) 1438
apoptosis (1411) 1411
care and treatment (1399) 1399
glioblastoma - pathology (1340) 1340
surgery (1332) 1332
brain cancer (1304) 1304
treatment outcome (1287) 1287
dacarbazine - therapeutic use (1267) 1267
malignant glioma (1258) 1258
medicine & public health (1230) 1230
research (1200) 1200
expression (1192) 1192
analysis (1135) 1135
brain neoplasms - therapy (1083) 1083
antineoplastic agents, alkylating - therapeutic use (1080) 1080
brain neoplasms - genetics (987) 987
neurology (966) 966
brain neoplasms - mortality (960) 960
mice (940) 940
radiation therapy (937) 937
therapy (921) 921
retrospective studies (892) 892
concomitant (877) 877
radiation (877) 877
bevacizumab (875) 875
glioma - drug therapy (872) 872
radiation-therapy (859) 859
brain (836) 836
medical prognosis (821) 821
patients (809) 809
glioblastoma - genetics (803) 803
combined modality therapy (802) 802
glioma - pathology (798) 798
glioblastoma - therapy (788) 788
health aspects (787) 787
multiforme (784) 784
dacarbazine - administration & dosage (780) 780
young adult (773) 773
phase-ii (760) 760
neurosciences (753) 753
dacarbazine - pharmacology (749) 749
cell biology (747) 747
glioblastoma - mortality (747) 747
newly-diagnosed glioblastoma (741) 741
pharmacology & pharmacy (735) 735
phase-ii trial (730) 730
aged, 80 and over (729) 729
magnetic resonance imaging (727) 727
mgmt (727) 727
trial (712) 712
brain neoplasms - metabolism (710) 710
brain neoplasms - radiotherapy (698) 698
dna methylation (684) 684
cancer therapies (680) 680
survival analysis (665) 665
antineoplastic agents - therapeutic use (659) 659
glioblastoma - metabolism (659) 659
disease-free survival (657) 657
gene expression (650) 650
antineoplastic combined chemotherapy protocols - therapeutic use (649) 649
glioblastoma-multiforme (633) 633
adolescent (627) 627
methylation (621) 621
proteins (615) 615
clinical trials (612) 612
radiology, nuclear medicine & medical imaging (595) 595
malignant gliomas (594) 594
antineoplastic agents (580) 580
drug therapy (576) 576
development and progression (564) 564
survival rate (563) 563
cells (554) 554
mutation (546) 546
growth (544) 544
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11554) 11554
French (110) 110
German (77) 77
Japanese (50) 50
Spanish (32) 32
Chinese (21) 21
Portuguese (21) 21
Czech (15) 15
Polish (12) 12
Korean (10) 10
Turkish (7) 7
Hungarian (6) 6
Norwegian (6) 6
Italian (5) 5
Russian (4) 4
Danish (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuro-oncology (Charlottesville, Va.), ISSN 1523-5866, 2013, Volume 15, Issue 1, pp. 4 - 27
Journal Article
Cancer gene therapy, ISSN 0929-1903, 02/2019, Volume 26, Issue 7-8, pp. 257 - 257
All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People's... 
Temozolomide
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 916 - 926
Journal Article
Journal of neuro-oncology, ISSN 1573-7373, 2018, Volume 138, Issue 3, pp. 627 - 636
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 6, pp. e0217881 - e0217881
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 10/2017, Volume 99, Issue 2, pp. E62 - E62
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 8, pp. 699 - 708
Journal Article
Journal Article
Brain metastasis-evidence based management, 12/2006
Advances in cancer management have resulted in a significant increase in median survival of number of diseases. Consequently we are seeing more patients living... 
Brain Metastasis, Management, Temozolomide
Journal
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 7, pp. 707 - 715
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2015, Volume 92, Issue 5, pp. 986 - 992
Purpose Valproic acid (VPA) is an antiepileptic agent with histone deacetylase inhibitor (HDACi) activity shown to sensitize glioblastoma (GBM) cells to... 
Radiology | Hematology, Oncology and Palliative Medicine | PLUS TEMOZOLOMIDE | MALIGNANT GLIOMA | SURVIVAL | ONCOLOGY | NEWLY-DIAGNOSED GLIOBLASTOMA | CONCOMITANT | RANDOMIZED-TRIAL | RADIOTHERAPY | MULTIFORME | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ERLOTINIB | ADJUVANT TEMOZOLOMIDE | Multivariate Analysis | Dacarbazine - adverse effects | Age Factors | Dacarbazine - therapeutic use | Humans | Middle Aged | Male | Bone Marrow - radiation effects | Glioblastoma - radiotherapy | Radiation-Sensitizing Agents - administration & dosage | Time Factors | Brain Neoplasms - blood | Dacarbazine - analogs & derivatives | Valproic Acid - blood | Adult | Female | Brain Neoplasms - mortality | Chemotherapy, Adjuvant | Brain Neoplasms - radiotherapy | Valproic Acid - adverse effects | Bone Marrow - drug effects | Chemoradiotherapy - methods | Drug Administration Schedule | Glioblastoma - blood | Kaplan-Meier Estimate | Brain Neoplasms - drug therapy | Radiation-Sensitizing Agents - adverse effects | Disease Progression | Antineoplastic Agents, Alkylating - therapeutic use | Radiation Tolerance - drug effects | Disease-Free Survival | Valproic Acid - administration & dosage | Radiation-Sensitizing Agents - metabolism | Aged | Histone Deacetylase Inhibitors - therapeutic use | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Glioblastoma - mortality | Histone Deacetylase Inhibitors - adverse effects | Divalproex | Care and treatment | Analysis | Radiation | Temozolomide | Radiotherapy | Valproic acid | Glioblastoma multiforme | Index Medicus | GLIOMAS | DIAGNOSIS | PATIENTS | DISEASE INCIDENCE | RADIOLOGY AND NUCLEAR MEDICINE | BONE MARROW | RADIATION DOSES | TOXICITY | COMPARATIVE EVALUATIONS | BLOOD
Journal Article